{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:18:00Z","timestamp":1779211080109,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C21244\/A19029"],"award-info":[{"award-number":["C21244\/A19029"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A causal role of high-risk HPV in oesophageal adenocarcinoma development has been hypothesised, but longitudinal evidence is limited. This study aims to investigate a potential causal role of infectious agents in the malignant progression of Barrett\u2019s oesophagus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using a retrospective nested case-control study design, index Barrett\u2019s biopsies were retrieved for individuals within the Northern Ireland Barrett\u2019s oesophagus register who subsequently progressed to oesophageal adenocarcinoma (<jats:italic>n<\/jats:italic>\u2009=\u2009150) and matched non-progressors (<jats:italic>n<\/jats:italic>\u2009=\u2009298). Index Barrett\u2019s biopsies were assessed for the presence of 142 infectious agents by multiplex polymerase chain reaction using the Luminex platform. RNA in-situ hybridisation assessed persistent transcriptional activity in subsequent tissue samples, for infectious agents detected more frequently in progressors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>High-risk HPV genotypes (HPV16 and HPV18) were only identified in the index biopsies of progressors but not non-progressors (4% [5\/150] versus 0% [0\/298], <jats:italic>P<\/jats:italic>\u2009=\u20090.004), though no signs of persistence or transcriptional activity were observed in subsequent tissue. Prevalence of infections did not differ between progressors and non-progressors for any other infectious agents, including Helicobacter Pylori and Herpes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Despite a higher prevalence of high-risk HPV in progressors than non-progressors, no evidence of transcriptionally active high-risk HPV was observed in subsequent samples, indicating presence in Barrett\u2019s is likely non-causal.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41416-025-03003-7","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T16:21:34Z","timestamp":1744129294000},"page":"1050-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Infectious agents and progression from Barrett\u2019s oesophagus to oesophageal adenocarcinoma: a nested case-control study"],"prefix":"10.1038","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8170-0989","authenticated-orcid":false,"given":"Talita H. A.","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1000-3649","authenticated-orcid":false,"given":"Lesley A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie G.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen G.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik","family":"Gheit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"McKay-Chopin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Jamison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian T.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-4335","authenticated-orcid":false,"given":"Christopher R.","family":"Cardwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6945-6060","authenticated-orcid":false,"given":"Jacqueline A.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Kunzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"3003_CR1","doi-asserted-by":"crossref","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Heal. 2020 Feb;8:e1.","DOI":"10.1016\/S2214-109X(19)30488-7"},{"key":"3003_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/hed.22015","volume":"35","author":"H Mehanna","year":"2013","unstructured":"Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35:747\u201355.","journal-title":"Head Neck"},{"key":"3003_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/infdis\/jis698","volume":"207","author":"X Li","year":"2013","unstructured":"Li X, Gao L, Li H, Gao J, Yang Y, Zhou F, et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis. 2013;207:479\u201388.","journal-title":"J Infect Dis"},{"key":"3003_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/apt.12574","volume":"39","author":"X Li","year":"2014","unstructured":"Li X, Gao C, Yang Y, Zhou F, Li M, Jin Q, et al. Systematic review with meta-analysis: The association between human papillomavirus infection and oesophageal cancer. Aliment Pharm Ther. 2014;39:270\u201381.","journal-title":"Aliment Pharm Ther"},{"key":"3003_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H zur Hausen","year":"2009","unstructured":"zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account [Internet]. Virology. 2009;384:260\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19135222\/","journal-title":"Virology"},{"key":"3003_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/ajg.2013.94","volume":"108","author":"S Rajendra","year":"2013","unstructured":"Rajendra S, Wang B, Snow ET, Sharma P, Pavey D, Merrett N, et al. Transcriptionally active human papillomavirus is strongly associated with Barrett\u2019s dysplasia and esophageal adenocarcinoma. Am J Gastroenterol. 2013;108:1082\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23588239\/","journal-title":"Am J Gastroenterol"},{"key":"3003_CR7","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/ijc.30896","volume":"141","author":"S Rajendra","year":"2017","unstructured":"Rajendra S, Yang T, Xuan W, Sharma P, Pavey D, Lee CS, et al. Active human papillomavirus involvement in Barrett\u2019s dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway. Int J cancer. 2017;141:2037\u201349. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28722212\/","journal-title":"Int J cancer"},{"key":"3003_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ijc.30059","volume":"139","author":"M Von Knebel D\u00f6beritz","year":"2016","unstructured":"Von Knebel D\u00f6beritz M. The causal role of human papillomavirus infections in non-anogenital cancers. It\u2019s time to ask for the functional evidence. Int J Cancer. 2016;139:9\u201311.","journal-title":"Int J Cancer"},{"key":"3003_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/S0016-5085(89)80011-3","volume":"96","author":"W Hameeteman","year":"1989","unstructured":"Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett\u2019s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249\u201356.","journal-title":"Gastroenterology"},{"key":"3003_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.canep.2012.07.009","volume":"36","author":"AT Gavin","year":"2012","unstructured":"Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505\u201312.","journal-title":"Cancer Epidemiol"},{"key":"3003_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2013.08.017","volume":"345","author":"ME Kavanagh","year":"2014","unstructured":"Kavanagh ME, O\u2019Sullivan KE, O\u2019Hanlon C, O\u2019Sullivan JN, Lysaght J, Reynolds JV. The esophagitis to adenocarcinoma sequence; the role of inflammation. Cancer Lett. 2014;345:182\u20139.","journal-title":"Cancer Lett"},{"key":"3003_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/1940-6207.CAPR-08-0109","volume":"1","author":"F Islami","year":"2008","unstructured":"Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Philos). 2008;1:329\u201338.","journal-title":"Cancer Prev Res (Philos)"},{"key":"3003_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/MEG.0000000000000868","volume":"29","author":"AT Kunzmann","year":"2017","unstructured":"Kunzmann AT, Graham S, McShane CM, Doyle J, Tommasino M, Johnston B, et al. The prevalence of viral agents in esophageal adenocarcinoma and Barrett\u2019s esophagus: A systematic review [Internet]. Eur J Gastroenterol Hepatol. 2017;29:817\u201325. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28252462\/","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3003_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT. et al. Risk of malignant progression in Barrett\u2019s Esophagus patients: Results from a large population-based study. J Natl Cancer Inst. 2011;103:1049\u201357.","journal-title":"J Natl Cancer Inst"},{"key":"3003_CR15","unstructured":"Northern Ireland Statistics and Research Agency. Census 2021 [Internet]. 2022 [cited 2022 Nov 18]. p. Acessed on 18 of November of 2022, at 16:42. Available from: https:\/\/www.nisra.gov.uk\/statistics\/census\/2021-census"},{"key":"3003_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/ojb.47","volume":"5","author":"C Lewis","year":"2018","unstructured":"Lewis C, McQuaid S, Clark P, Murray P, McGuigan T, Greene C, et al. The Northern Ireland Biobank: A Cancer Focused Repository of Science. Open J Bioresour [Internet]. 2018;5:9. Available from: https:\/\/pure.qub.ac.uk\/en\/publications\/the-northern-ireland-biobank-a-cancer-focused-repository-of-scien","journal-title":"Open J Bioresour [Internet]"},{"key":"3003_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/1055-9965.EPI-19-0538","volume":"29","author":"SG Craig","year":"2020","unstructured":"Craig SG, Anderson LA, Moran M, Graham L, Currie K, Rooney K, et al. Comparison of molecular assays for HPV testing in oropharyngeal squamous cell carcinomas: A population-based study in Northern Ireland. Cancer Epidemiol Biomark Prev [Internet]. 2020;29:31\u20138. Available from: https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0538.","journal-title":"Cancer Epidemiol Biomark Prev [Internet]"},{"key":"3003_CR18","unstructured":"de Oliveira THA, do Amaral CM, de Fran\u00e7a S\u00e3o Marcos B, Nascimento KCG, de Miranda Rios AC, Quixabeira DCA, et al. Presence and activity of HPV in primary lung cancer. J Cancer Res Clin Oncol Available from: http:\/\/link.springer.com\/10.1007\/s00432-018-2748-8"},{"key":"3003_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13027-019-0235-8","volume":"14","author":"EM Silva","year":"2019","unstructured":"Silva EM, Mariano VS, Pastrez PRA, Pinto MC, Nunes EM, Sichero L, et al. Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study. Infect Agent Cancer. 2019;14:12\u20138.","journal-title":"Infect Agent Cancer"},{"key":"3003_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/jmv.24447","volume":"88","author":"LA Anderson","year":"2016","unstructured":"Anderson LA, O\u2019Rorke MA, Wilson R, Jamison J, Gavin AT. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland. J Med Virol [Internet]. 2016;88:1262\u201370. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26680281\/","journal-title":"J Med Virol [Internet]"},{"key":"3003_CR21","first-page":"1319","volume":"24","author":"E Acevedo-Nu\u00f1o","year":"2004","unstructured":"Acevedo-Nu\u00f1o E, Gonz\u00e1lez-Ojeda A, V\u00e1zquez-Camacho G, Ma ABPL, Moreno-Villa H, Montoya-Fuentes H. Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett\u2019s oesophagus and oesophagitis. Anticancer Res [Internet] 2004;24:1319\u201323. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15154668\/","journal-title":"Anticancer Res [Internet]"},{"key":"3003_CR22","doi-asserted-by":"crossref","unstructured":"Parameshwaran K, Sharma P, Rajendra S, Stelzer-Braid S, Xuan W, Rawlinson WD Circulating human papillomavirus DNA detection in Barrett\u2019s dysplasia and esophageal adenocarcinoma. Dis Esophagus [Internet]. 2020 Jan [cited 2021 Jul 27];32. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31313804\/","DOI":"10.1093\/dote\/doz064"},{"key":"3003_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/nyas.14509","volume":"1482","author":"S Rajendra","year":"2020","unstructured":"Rajendra S, Pavey D, McKay O, Merrett N, Gautam SD. Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review [Internet]. Ann N. Y Acad Sci. 2020;1482:36\u201348. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33103249\/","journal-title":"Ann N. Y Acad Sci"},{"key":"3003_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.2009.067447","volume":"63","author":"S Rajendra","year":"2010","unstructured":"Rajendra S, Robertson IK. Similar immunogenetics of Barrett\u2019s oesophagus and cervical neoplasia: is HPV the common denominator? J Clin Pathol. 2010;63:1\u20133. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20026700\/","journal-title":"J Clin Pathol"},{"key":"3003_CR25","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1158\/1055-9965.EPI-18-0287","volume":"27","author":"I Agalliu","year":"2018","unstructured":"Agalliu I, Chen Z, Wang T, Hayes RB, Freedman ND, Gapstur SM, et al. Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiol Biomark Prev [Internet]. 2018;27:1168\u201375. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30087123\/","journal-title":"Cancer Epidemiol Biomark Prev [Internet]"},{"key":"3003_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/jamaoncol.2015.5504","volume":"2","author":"I Agalliu","year":"2016","unstructured":"Agalliu I, Gapstur S, Chen Z, Wang T, Anderson RL, Teras L, et al. Associations of Oral \u03b1-, \u03b2-, and \u03b3-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer. JAMA Oncol [Internet]. 2016;2:599\u2013606. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26794505\/","journal-title":"JAMA Oncol [Internet]"},{"key":"3003_CR27","doi-asserted-by":"crossref","unstructured":"Chang C, Worrell SG Viruses and esophageal cancer. Dis esophagus Off J Int Soc Dis Esophagus [Internet]. 2020 Dec [cited 2024 Jan 11];33. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32462190\/","DOI":"10.1093\/dote\/doaa036"},{"key":"3003_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gut.2007.132068","volume":"57","author":"DA Corley","year":"2008","unstructured":"Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, et al. Helicobacter Pylori Infection and the Risk of Barrett\u2019s Oesophagus: A Community-Based Study. Gut [Internet]. 2008;57:727. Available from: https:\/\/doi.org\/10.1136\/gut.2007.132068","journal-title":"Gut [Internet]"},{"key":"3003_CR29","doi-asserted-by":"crossref","unstructured":"Holleczek B, Sch\u00f6ttker B, Brenner H Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study. 2019;","DOI":"10.1002\/ijc.32610"},{"key":"3003_CR30","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41395-018-0070-3","volume":"113","author":"Z Wang","year":"2018","unstructured":"Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, et al. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett\u2019s Esophagus: An Analysis of the Barrett\u2019s and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol [Internet]. 2018;113:1148\u201355. Available from: https:\/\/journals.lww.com\/ajg\/Fulltext\/2018\/08000\/Helicobacter_pylori_Infection_Is_Associated_With.13.aspx","journal-title":"Am J Gastroenterol [Internet]"},{"key":"3003_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2024.03.016","volume":"167","author":"AK Wiklund","year":"2024","unstructured":"Wiklund AK, Santoni G, Yan J, Radkiewicz C, Xie S, Birgisson H, et al. Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment in a Population-Based Multinational Cohort Study. Gastroenterol [Internet]. 2024;167:485\u2013492.e3. Available from: https:\/\/doi.org\/10.1053\/j.gastro.2024.03.016.","journal-title":"Gastroenterol [Internet]"},{"key":"3003_CR32","doi-asserted-by":"crossref","unstructured":"Schroder J, Chegwidden L, Maj C, Gehlen J, Speller J, Bohmer AC, et al. GWAS meta-analysis of 16 790 patients with Barrett\u2019s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level. Gut [Internet]. 2022 [cited 2022 Dec 1]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35882562\/","DOI":"10.1136\/gutjnl-2021-326698"},{"key":"3003_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cgh.2013.08.029","volume":"12","author":"JH Rubenstein","year":"2014","unstructured":"Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M, et al. Association between Helicobacter pylori and Barrett\u2019s Esophagus, Erosive Esophagitis, and Gastroesophageal Reflux Symptoms. Clin Gastroenterol Hepatol [Internet]. 2014;12:239. Available from: https:\/\/doi.org\/10.1016\/j.cgh.2013.08.029","journal-title":"Clin Gastroenterol Hepatol [Internet]"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03003-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:14:11Z","timestamp":1748448851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03003-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,6,18]]}},"alternative-id":["3003"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03003-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Office of Research Ethics Committees Northern Ireland (ORECNI) granted ethical approval for the NIBR (Ref:15\/NI\/0203) to collect information without consent. Individuals have a right to opt out of registration. Ethical approval for the study of infectious agents and Barrett\u2019s progression was granted under approvals from the ORECNI (Ref:15\/NI\/0233) and the Northern Ireland Biobank (Ref: NIB15-0146). Further approval for the HPV RNA-ISH analysis was also granted by the Northern Ireland Biobank (Ref: NIB22-0014). The Northern Ireland Biobank has ethical approval from ORECNI (Ref: 21\/NI\/0019) for the consent, collection, storage, and release of de-identified human tissue samples for research, and this approval extends to the NIB projects referenced above. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The ethical approval from the NIBR allows the use of anonymized patient data for research and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}